Provided by Tiger Fintech (Singapore) Pte. Ltd.

EyePoint

6.58
+0.50008.22%
Pre-market: 6.47-0.1100-1.67%08:31 EST
Volume:963.28K
Turnover:6.12M
Market Cap:449.09M
PE:-3.22
High:6.61
Open:6.33
Low:5.94
Close:6.08
Loading ...

EyePoint Pharmaceuticals (EYPT) Reports Q3 Loss, Lags Revenue Estimates

Zacks
·
07 Nov 2024

BRIEF-EyePoint Pharmaceuticals Reports Q3 2024 Financial Results And Highlights Recent Corporate Developments

Reuters
·
07 Nov 2024

EyePoint Pharmaceuticals: Q3 Earnings Snapshot

Associated Press Finance
·
07 Nov 2024

EyePoint Pharmaceuticals Q3 Operating Expenses USD 43.272 Million

THOMSON REUTERS
·
07 Nov 2024

EyePoint Pharmaceuticals Reports Third Quarter 2024 Financial Results and Highlights Recent Corporate Developments

THOMSON REUTERS
·
07 Nov 2024

EyePoint Pharmaceuticals Inc: $161.0 Mln Oversubscribed Equity Financing Extends Cash Runway Into 2027

THOMSON REUTERS
·
07 Nov 2024

EyePoint Pharmaceuticals Reports Third Quarter 2024 Financial Results and Highlights Recent Corporate Developments

GlobeNewswire
·
07 Nov 2024

EyePoint Pharmaceuticals Inc expected to post a loss of 55 cents a share - Earnings Preview

Reuters
·
06 Nov 2024

With 61% ownership, EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) boasts of strong institutional backing

Simply Wall St.
·
05 Nov 2024

EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences

GlobeNewswire
·
04 Nov 2024

Press Release: EyePoint Pharmaceuticals Announces Closing of Upsized Public Offering and Full Exercise of Option to Purchase Additional Shares

Dow Jones
·
01 Nov 2024

EyePoint Pharmaceuticals Prices $140 Million Public Offering

MT Newswires Live
·
30 Oct 2024

Stock Track | EyePoint Stock Plunges Over 8% on $100M Stock Offering Despite Positive Trial Data

Stock Track
·
30 Oct 2024

BRIEF-Eyepoint Pharmaceuticals Prices Public Offering Of 12.7 Mln Shares At $11.00 Each

Reuters
·
30 Oct 2024

EyePoint Pharmaceuticals Inc - Prices Public Offering of 12.7 Mln Shares at $11.00 Each

THOMSON REUTERS
·
30 Oct 2024

EyePoint Pharmaceuticals Announces Pricing of Upsized Public Offering

GlobeNewswire
·
30 Oct 2024